Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
5.45
-0.29 (-5.05%)
At close: Oct 29, 2025, 4:00 PM EDT
5.48
+0.03 (0.55%)
After-hours: Oct 29, 2025, 4:18 PM EDT
Nephros Revenue
Nephros had revenue of $4.42M in the quarter ending June 30, 2025, with 35.89% growth. This brings the company's revenue in the last twelve months to $16.68M, up 21.16% year-over-year. In the year 2024, Nephros had annual revenue of $14.16M, down -0.53%.
Revenue (ttm)
$16.68M
Revenue Growth
+21.16%
P/S Ratio
3.64
Revenue / Employee
$538,194
Employees
31
Market Cap
57.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.16M | -76.00K | -0.53% |
| Dec 31, 2023 | 14.24M | 4.26M | 42.74% |
| Dec 31, 2022 | 9.98M | -242.00K | -2.37% |
| Dec 31, 2021 | 10.22M | 1.66M | 19.34% |
| Dec 31, 2020 | 8.56M | -1.77M | -17.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
NEPH News
- 2 months ago - Nephros, Inc. (NEPH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Nephros Announces Strong Second Quarter Financial Results - GlobeNewsWire
- 3 months ago - Nephros Schedules Second Quarter 2025 Financial Results Conference Call - GlobeNewsWire
- 11 months ago - Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC - GlobeNewsWire
- 1 year ago - Nephros, Inc. (NEPH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Nephros Schedules Third Quarter 2024 Financial Results Conference Call - GlobeNewsWire
- 1 year ago - Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton - GlobeNewsWire
- 1 year ago - Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript - Seeking Alpha